Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

GMP in India

The Importance of Documentation and Record-Keeping for Schedule M Revised Compliance

Posted on January 24, 2025 By digi

The Importance of Documentation and Record-Keeping for Schedule M Revised Compliance Why Documentation and Record-Keeping Are Critical for Schedule M Revised Compliance Introduction to Documentation in GMP Documentation and record-keeping are the backbone of Good Manufacturing Practices (GMP). For pharmaceutical manufacturers in India, the revised Schedule M under the Drugs and Cosmetics Rules, 1945, emphasizes…

Read More “The Importance of Documentation and Record-Keeping for Schedule M Revised Compliance” »

GMP in India

How to Prepare for Schedule M Revised Inspections and Audits in India

Posted on January 25, 2025 By digi

How to Prepare for Schedule M Revised Inspections and Audits in India Tips to Successfully Prepare for Schedule M Revised Inspections and Audits Introduction to Schedule M Revised Inspections Inspections and audits under Schedule M Revised are critical for ensuring that pharmaceutical manufacturers in India comply with updated Good Manufacturing Practices (GMP). These inspections verify…

Read More “How to Prepare for Schedule M Revised Inspections and Audits in India” »

GMP in India

The Role of Quality Control and Quality Assurance under Schedule M Revised

Posted on January 26, 2025 By digi

The Role of Quality Control and Quality Assurance under Schedule M Revised Understanding Quality Control and Assurance in Schedule M Revised Introduction to Quality Control (QC) and Quality Assurance (QA) Ensuring the safety, efficacy, and quality of pharmaceutical products is the cornerstone of Good Manufacturing Practices (GMP). Under the revised Schedule M of the Drugs…

Read More “The Role of Quality Control and Quality Assurance under Schedule M Revised” »

GMP in India

How to Ensure Compliance with Schedule M Revised for Small Pharmaceutical Manufacturers in India

Posted on January 26, 2025 By digi

How to Ensure Compliance with Schedule M Revised for Small Pharmaceutical Manufacturers in India Tips for Small Pharmaceutical Manufacturers to Achieve Schedule M Revised Compliance Introduction to Schedule M Revised The revised Schedule M under the Drugs and Cosmetics Rules, 1945, introduces enhanced Good Manufacturing Practices (GMP) that align with global standards. While these changes…

Read More “How to Ensure Compliance with Schedule M Revised for Small Pharmaceutical Manufacturers in India” »

GMP in India

The Impact of Schedule M Revised on GMP Certification for Indian Pharmaceutical Manufacturers

Posted on January 27, 2025 By digi

The Impact of Schedule M Revised on GMP Certification for Indian Pharmaceutical Manufacturers How Schedule M Revised Shapes GMP Certification in India Introduction to GMP Certification and Schedule M Revised Good Manufacturing Practices (GMP) certification is a globally recognized standard that ensures pharmaceutical products are consistently produced and controlled according to quality standards. In India,…

Read More “The Impact of Schedule M Revised on GMP Certification for Indian Pharmaceutical Manufacturers” »

GMP in India

How Schedule M Revised Supports Drug Manufacturing and Export to Global Markets

Posted on January 27, 2025 By digi

How Schedule M Revised Supports Drug Manufacturing and Export to Global Markets A Step-by-Step Guide to Leveraging Schedule M Revised for Global Pharmaceutical Exports Introduction to Schedule M Revised and Global Markets Schedule M Revised, under the Drugs and Cosmetics Rules, 1945, represents a significant step in aligning India’s pharmaceutical manufacturing standards with international Good…

Read More “How Schedule M Revised Supports Drug Manufacturing and Export to Global Markets” »

GMP in India

The Relationship Between Schedule M Revised and Drug Regulatory Authorities in India

Posted on January 28, 2025 By digi

The Relationship Between Schedule M Revised and Drug Regulatory Authorities in India Understanding the Role of Drug Regulatory Authorities in Enforcing Schedule M Revised Introduction to Schedule M Revised and Drug Regulation Schedule M Revised, under the Drugs and Cosmetics Rules, 1945, plays a crucial role in defining Good Manufacturing Practices (GMP) for the Indian…

Read More “The Relationship Between Schedule M Revised and Drug Regulatory Authorities in India” »

GMP in India

Common Non-Conformities in Schedule M Revised Compliance and How to Address Them

Posted on January 28, 2025 By digi

Common Non-Conformities in Schedule M Revised Compliance and How to Address Them Tips to Avoid and Address Common Non-Conformities in Schedule M Revised Compliance Introduction to Schedule M Revised Compliance The revised Schedule M under the Drugs and Cosmetics Rules, 1945, aims to elevate India’s pharmaceutical manufacturing standards to align with global Good Manufacturing Practices…

Read More “Common Non-Conformities in Schedule M Revised Compliance and How to Address Them” »

GMP in India

How Schedule M Revised Ensures Compliance in the Manufacturing of Generic Drugs in India

Posted on January 29, 2025 By digi

How Schedule M Revised Ensures Compliance in the Manufacturing of Generic Drugs in India Understanding the Role of Schedule M Revised in Generic Drug Manufacturing Compliance Introduction to Schedule M Revised and Generic Drugs India is one of the largest producers of generic drugs, supplying affordable medicines to global markets. With the revision of Schedule…

Read More “How Schedule M Revised Ensures Compliance in the Manufacturing of Generic Drugs in India” »

GMP in India

The Role of Facility Design in Achieving Compliance with Schedule M Revised

Posted on January 29, 2025 By digi

The Role of Facility Design in Achieving Compliance with Schedule M Revised How to Design Pharmaceutical Facilities for Schedule M Revised Compliance Introduction to Facility Design and Schedule M Revised Facility design is a cornerstone of Good Manufacturing Practices (GMP) and plays a critical role in ensuring compliance with the revised Schedule M under the…

Read More “The Role of Facility Design in Achieving Compliance with Schedule M Revised” »

GMP in India

Posts pagination

Previous 1 2 3 … 6 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme